Sector: Pharmaceuticals & Biotechnology

Mid Cap

Caplin Point Labs Share Price

CAPLIPOINT

₹2,502.10

-58.70(-2.29%)

24th Aug 2026 | 12:55 PM

NSE : CAPLIPOINT

Open Free Demat Account

Caplin Point Labs Performance

Price Movement

₹2502.10

₹2473.90

₹2555.60

↘ Today's Low↗ Today's High

1 Year Performance

₹2502.10

₹1500.30

₹2699.00

↘ 52 Week Low↗ 52 Week High

Markets Today

High₹2,555.60

Low₹2,473.90

Open at₹2,545.00

Prev Close₹2,560.80

Volumes1.61 L

Avg Price₹2,512.78

Lower Circuit₹2,048.70

Upper Circuit₹3,072.90

Historical Performance

3M High₹2,699.00

3M Low₹1,950.00

1 Yr High₹2,699.00

1 Yr Low₹1,500.30

3 Yr High₹2,699.00

3 Yr Low₹954.00

5 Yr High₹2,699.00

5 Yr Low₹575.00

Summary

As of 24-08-2026 13:23, Caplin Point Laboratories Ltd. share price today is ₹0, with a change of ₹-2560.80 (-100.00%) from the previous close of ₹2560.8. The stock opened at ₹2545 and traded between ₹2473.9 and ₹2555.6, with a total traded volume of 161433 shares. The company has a market capitalization of ₹19542.6 Cr in the Pharmaceuticals & Biotechnology sector. while its 52-week high and low are ₹2699 and ₹1500.3, respectively.

Caplin Point Laboratories Ltd. valuation metrics include a P/E ratio of 29.4, EPS of ₹84.36, and book value of ₹5.40. Profitability indicators show ROE of 17.87% along with a dividend yield of 0.3%. Caplin Point Laboratories Ltd. has reported revenue of ₹2287.33 Cr and net profit of ₹665.35 Cr.

Caplin Point Laboratories Ltd. technical indicators include Day RSI at 53.08, Day MFI at 53.37, Day ADX at 23.76. Additional indicators include Commodity Channel Index (CCI) at 13.8 and Williams %R at -34.91. Momentum indicators show Day MACD at 4.65, Day MACD Signal Line at 13.61, DayATR at 89.11. Rate of Change indicators for Caplin Point Laboratories Ltd. include ROC125 at 48.51 and ROC21 at -1.42.

Exponential moving averages include EMA5 at ₹2539.2, EMA10 at ₹2542, EMA12 at ₹2544.1, EMA20 at ₹2546.5, EMA26 at ₹2539.4, EMA50 at ₹2461.2, EMA100 at ₹2289.9, EMA200 at ₹2135.7. Simple moving averages include SMA5 at ₹2520.6, SMA10 at ₹2548.9, SMA20 at ₹2549.9, SMA30 at ₹2571.6, SMA50 at ₹2534.7, SMA100 at ₹2181.7, SMA150 at ₹2031.8, SMA200 at ₹2005.

Support levels for Caplin Point Labs are placed at First Support ₹2528.53, Second Support ₹2486.07, Third Support ₹2455.83. Resistance levels are seen at First Resistance ₹2601.23, Second Resistance ₹2631.47, Third Resistance ₹2673.93. Caplin Point Laboratories Ltd. shareholding pattern shows promoter holding at 70.57%, FII holding at 5.76%, DII holding at 0%, public holding at 21.19%.

Caplin Point Labs Fundamentals

Market Cap

High in industry

19,542.60 Cr.

PE Ratio (TTM)

Above industry Median

29.40

Dividend Yield

Below industry Median

0.30

Net Profit TTM

17.7% incr over last year

665.35

Net Profit Growth

17.7% incr over last year

665.35

PEG Ratio

High in industry

1.70

ROE

8% decr over last year

17.87

Operating Revenue TTM

2,287.33

Operating Revenue Growth

15.0% incr over last year

Book Value

Above industry Median

5.40

MFI

MFI is mid-range

53.37

RSI

RSI is mid-range

53.08

EPS (TTM)

84.36

Debt to Equity

Face Value

Operating Profit Margin Qtr.

33.04

Operating Profit Qtr.

213.48

Net Profit Qtr.

176.91

Operating Revenue Qtr.

610.36

PB Ratio

5.40

Caplin Point Labs Financials

*All values are in Rs. Cr

Loading chart...

Indicator	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025
Total Revenue	202.95	191.36	189.22	175.18	182.57
Operating Expense	108.54	107.77	97.50	99.33	95.96
Operating Profit	94.41	83.59	91.72	75.85	86.61
Depreciation	6.56	6.90	6.37	6.02	6.14
Interest	0.05	0.05	0.07	0.05	0.04
Tax	30.21	28.22	29.73	26.41	26.57
Net Profit	120.38	109.50	87.28	102.59	85.89

Caplin Point Labs Technicals

Caplin Point Laboratories Ltd. EMA & SMA

₹2502.10

-27.60 (-1.09%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹2539.2

Day EMA10 ₹2542

Day EMA12 ₹2544.1

Day EMA20 ₹2546.5

Day EMA26 ₹2539.4

Day EMA50 ₹2461.2

Day EMA100 ₹2289.9

Day EMA200 ₹2135.7

Caplin Point Labs Support and Resistance

Resistance

First Resistance₹2601.23

Second Resistance₹2631.47

Third Resistance₹2673.93

Support

First Support₹2528.53

Second Support₹2486.07

Third Support₹2455.83

Technical Indicators

Day RSI53.08

Day MFI53.37

Day ADX23.76

Day Commodity Channel Index13.80

William-34.91

Day MACD4.65

Day MACD Signal Line13.61

Day ATR89.11

Day ROC12548.51

Day ROC21-1.42

Caplin Point Labs Shareholding Pattern

Held By	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Promoter	70.6	70.6	70.6	70.6	70.6	70.6
FII	5.7	6.2	6.5	6.6	6.2	5.8
DII	2	2.2	2.1	2	2.1	2.4
Public	21.7	21.1	20.8	20.8	21.1	21.2

Caplin Point Labs Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	43.67 K	84.53 K	51.66%
Week	40.97 K	93.94 K	43.61%
1 Month	48.81 K	1.16 L	42.10%
6 Month	59.1 K	1.53 L	38.72%

Caplin Point Labs SWOT Analysis

Strengths22

Weakness6

Opportunity1

Threats1

Benjamin Graham Value Screen

Price crossing above SMA20 today, and greater than SMA5

Strong Performer, Getting Expensive (DVM)

30 Day SMA crossing over 200 Day SMA, and current price greater than open

Companies with 10% increase in share price over three months, with rising net profit growth

Strong Momentum: Price above short, medium and long term moving averages

Consistent high performing stocks over Five Years

Annual Profit Growth higher than Sector Profit Growth

PEG lower than Industry PEG

High Momentum Scores (Technical Scores greater than 50)

Increasing Revenue every Quarter for the past 8 Quarters

Growth in Net Profit with increasing Profit Margin (QoQ)

Companies with Low Debt

Increasing Revenue every Quarter for the past 4 Quarters

Increasing profits every quarter for the past 4 quarters

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Annual Net Profits improving for last 2 years

Book Value per share Improving for last 2 years

Companies with Zero Promoter Pledge

Near 52 Week High

Top Gainers

Stocks Outperforming their Industry Price Change in the Quarter

Caplin Point Labs Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
18 Sep, 2026	4	FINAL	18 Sep, 2026	Equity Share
29 May, 2026	4	INTERIM	30 May, 2026	Equity Share
12 Sep, 2025	3	FINAL	12 Sep, 2025	Equity Share
30 May, 2025	3	INTERIM	30 May, 2025	Equity Share
23 Sep, 2024	2.5	FINAL		Equity Share
31 May, 2024	2.5	INTERIM	31 May, 2024	Equity Share
14 Sep, 2023	2.5	FINAL		Equity Share
09 Jun, 2023	2	INTERIM	09 Jun, 2023	Equity Share
21 Sep, 2022	2	FINAL		Equity Share
23 May, 2022	2	INTERIM	24 May, 2022	Equity Share

Caplin Point Labs Stock Comparison

Financials	Corona Remedies Ltd.	Sudeep Pharma Ltd.	Senores Pharmaceuticals Ltd.	OneSource Specialty Pharma Ltd.	Sanofi Consumer Healthcare India Ltd.	Akums Drugs & Pharmaceuticals Ltd.
Price (₹)	₹2,142.40	₹1,112	₹1,567.40	₹1,521.20	₹4,224.10	₹769.50
% Change	-0.01%	0.02%	3.57%	-0.90%	0.05%	2.60%
Revenue TTM (₹ Cr)	₹1,479.07	₹675.61	₹691.72	₹1,543.34	₹949.80	₹4,501.61
Net Profit TTM (₹ Cr)	₹199.03	₹182.64	₹126.37	₹-48.62	₹266	₹291.72
PE TTM	65.20	71.50	56.50	-358.60	36.60	40.60
1 Year Return	99.76	95.01	121.72	-17.12	-19	57.13
ROCE	31.54	24.22	15.60	0.59	-	11.40

Similar Stocks

INNOVACAP

Innova Captab Ltd.

₹ 1064.90

-2.17%

BLUEJET

Blue Jet Healthcare Ltd

₹ 592.40

-0.63%

CONCORDBIO

Concord Biotech Ltd.

₹ 1542.00

-1.86%

AARTIPHARM

Aarti Pharmalabs Ltd.

₹ 834.50

+2.17%

SUPRIYA

Supriya Lifescience Ltd.

₹ 802.75

-0.34%

ALIVUS

Alivus Life Sciences Ltd.

₹ 1357.00

+0.45%

COHANCE

Cohance Lifesciences Ltd.

₹ 451.25

-2.54%

ERIS

Eris Lifesciences Ltd.

₹ 1325.00

-0.24%

SYNGENE

Syngene International Ltd.

₹ 401.15

-1.50%

APLLTD

Alembic Pharmaceuticals Ltd.

₹ 817.10

-0.57%

SPARC

Sun Pharma Advanced Research Company Ltd.

₹ 195.80

-0.46%

STAR

Strides Pharma Science Ltd.

₹ 982.20

-0.41%

FDC

FDC Ltd.

₹ 346.40

-0.63%

SHILPAMED

Shilpa Medicare Ltd.

₹ 851.60

+4.50%

JUBLPHARMA

Jubilant Pharmova Ltd.

₹ 894.00

+1.55%

NATCOPHARM

Natco Pharma Ltd.

₹ 885.00

+0.29%

MARKSANS

Marksans Pharma Ltd.

₹ 319.30

-0.62%

ORCHPHARMA

Orchid Pharma Ltd.

₹ 1031.65

+2.95%

VIYASH

Viyash Scientific Ltd.

₹ 268.45

-2.72%

ASTRAZEN

AstraZeneca Pharma India Ltd.

₹ 7219.00

-2.65%

BLISSGVS

Bliss GVS Pharma Ltd.

₹ 571.40

-1.33%

SANOFI

Sanofi India Ltd.

₹ 3288.00

-1.93%

MOREPENLAB

Morepen Laboratories Ltd.

₹ 96.51

+0.52%

PGHL

Procter & Gamble Health Ltd.

₹ 5858.50

+0.51%

FAQ's on CAPLIPOINT

What is the current share price of Caplin Point Laboratories Ltd.?

As of 6 June 2025 at 10:01 AM, the share price for Caplin Point Laboratories Ltd. is ₹ 2502.1 on the NSE and ₹ 2503.65 on the BSE. (Note: Prices are dynamic and update frequently during market hours).

What is the Market Capitalization of Caplin Point Laboratories Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 6 June 2025, the market cap for Caplin Point Laboratories Ltd. is approximately ₹ 19542.6 Cr.

What are the PE and PB ratios for Caplin Point Laboratories Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for Caplin Point Laboratories Ltd. is 29.4, and the Price-to-Book (PB) ratio is 5.4.

What is the 52-Week High and Low for Caplin Point Laboratories Ltd.?

Over the past 52 weeks, the highest price reached by Caplin Point Laboratories Ltd. shares was ₹ 2699, and the lowest price was ₹ 1500.3.

What is the current dividend yield for Caplin Point Laboratories Ltd.?

As of 6 June 2025, the dividend yield for Caplin Point Laboratories Ltd. is 0.3%. The dividend yield is calculated based on the company's annual dividend payouts relative to its current share price.

Who are the major shareholders of Caplin Point Laboratories Ltd.?

Significant shareholdings in Caplin Point Laboratories Ltd. typically include entities such as:

Promoter
Public
FII
Mutual Funds
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of Caplin Point Laboratories Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, Caplin Point Laboratories Ltd. is often compared with other major players such as Bio Medica Laboratories, Goldline Pharmaceutical, Sai Parenterals, Speciality Medicines, Accretion Nutraveda and Rekvina Laboratories for analysis and benchmarking.

What is the latest dividend information for Caplin Point Laboratories Ltd.?

Caplin Point Laboratories Ltd. last declared a FINAL dividend of ₹ 4 per share for the financial period ending 2026. The record date was set as 2026-09-18, and the payment was/is scheduled around 2026-09-18. For the most current dividend announcements, refer to official company filings.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy